Michael Xiang Selected Research

Therapeutics

12/2023	Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate Cancer.
3/2023	Brief Report: Severe Pneumonitis After Combined Thoracic Radiotherapy and Osimertinib.
1/2023	External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.
3/2022	Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.
1/2022	High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium.
1/2021	Prolongation of definitive head and neck cancer radiotherapy: Survival impact and predisposing factors.
1/2019	National patterns of care and cancer-specific outcomes of adjuvant treatment in patients with serous and clear cell endometrial carcinoma.
12/2018	Survival of patients with head and neck cancer treated with definitive radiotherapy and concurrent cisplatin or concurrent cetuximab: A Surveillance, Epidemiology, and End Results-Medicare analysis.
10/2016	Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anticancer agent.
4/2014	STAT3 Activity and Function in Cancer: Modulation by STAT5 and miR-146b.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Xiang Research Topics

Disease

27	Neoplasms (Cancer) 03/2023 - 04/2012
11	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 11/2015
3	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2022
3	Breast Neoplasms (Breast Cancer) 10/2022 - 01/2014
3	Endometrial Neoplasms (Endometrial Cancer) 07/2021 - 01/2019
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 12/2018
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2019 - 07/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 05/2020
2	Lung Neoplasms (Lung Cancer) 11/2023 - 12/2020
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2019
2	Adenocarcinoma 05/2020 - 01/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2020 - 01/2019
1	Oropharyngeal Neoplasms 10/2023
1	Pneumonia (Pneumonitis) 03/2023
1	Disease Progression 11/2022
1	AIDS-Related Complex (ARC) 07/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021
1	Endometrioid Carcinoma 07/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Residual Neoplasm 01/2020
1	Second Primary Neoplasms (Neoplasms, Second) 01/2020
1	Carcinoma (Carcinomatosis) 01/2019
1	Vomiting 01/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019
1	Hypovolemia 01/2019
1	Cytopenia 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Nausea 01/2019
1	Deglutition Disorders (Dysphagia) 12/2018
1	Dermatitis 12/2018
1	Mucositis 12/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2016
1	Multiple Myeloma 10/2016
1	Hematologic Neoplasms (Hematological Malignancy) 05/2014
1	Lymphoma (Lymphomas) 05/2014
1	Leukemia 05/2014
1	Inflammation (Inflammations) 01/2014
1	Wilms Tumor (Wilm's Tumor) 04/2010

Drug/Important Bio-Agent (IBA)

4	AntigensIBA 01/2023 - 12/2021
3	AndrogensIBA 01/2023 - 01/2022
3	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 12/2018
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 12/2021
2	Protons (Proton)IBA 12/2020 - 01/2020
2	Atovaquone (Mepron)FDA Link 12/2019 - 10/2016
2	Cetuximab (Erbitux)FDA Link 01/2019 - 12/2018
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 10/2016 - 01/2014
2	Transcription Factors (Transcription Factor)IBA 10/2016 - 05/2014
1	Prescription DrugsIBA 12/2023
1	osimertinibIBA 03/2023
1	SteroidsIBA 03/2023
1	Docetaxel (Taxotere)FDA Link 01/2023
1	GalliumIBA 01/2023
1	abirateroneIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 10/2022
1	Pyrimethamine (Daraprim)FDA Link 01/2021
1	GlutaminaseIBA 12/2020
1	boldenone undecylenate (Equipoise)IBA 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	Tyrosine Kinase InhibitorsIBA 05/2014
1	Proteins (Proteins, Gene)FDA Link 05/2014
1	CytokinesIBA 05/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	MicroRNAs (MicroRNA)IBA 01/2014
1	STAT5 Transcription FactorIBA 07/2012
1	Pimozide (Orap)FDA Link 07/2012
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 04/2010
1	A-Form DNA (A-DNA)IBA 04/2010

Therapy/Procedure

20	Radiotherapy 11/2023 - 11/2015
12	Therapeutics 12/2023 - 04/2012
9	Drug Therapy (Chemotherapy) 11/2023 - 01/2019
7	Brachytherapy 01/2023 - 11/2015
4	Hysterectomy 07/2021 - 01/2019
3	Neoadjuvant Therapy 10/2023 - 01/2020
2	Chemoradiotherapy 11/2023 - 01/2019
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2022 - 01/2020
2	Adjuvant Chemotherapy 07/2021 - 01/2020
1	Immunotherapy 10/2023
1	Adjuvant Radiotherapy 12/2020
1	Proton Therapy 01/2020
1	Conformal Radiotherapy 01/2020
1	Hematopoietic Stem Cell Transplantation 10/2016